Clik here to view.
Allergan acquires Zeltiq Aesthetics in $2.48B deal
Allergan (NYSE:AGN) said today that it will pay $2.48 billion for Zeltiq Aesthetics Inc. (NSDQ:ZLTQ) and its portfolio of body-contouring products. Zeltiq’s FDA-approved CoolSculpting system uses a...
View ArticleClik here to view.
Teva Pharmaceutical beats Q4 earnings, sales estimates
Shares in Teva Pharmaceutical (NYSE:TEVA) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results. The Israel-based company posted a loss of -$974...
View ArticleClik here to view.
Actelion reports income, revenue growth in FY2016
(Reuters) – Swiss drugmaker Actelion‘s 2016 core net income rose 27 percent on accelerating sales of its newer medicines to treat deadly pulmonary arterial hypertension (PAH), it said on Tuesday. Core...
View ArticleClik here to view.
Early collaboration is key in drug-device development, experts say
While pharmaceutical companies and medical device firms know that working together is a vital part of doing business, they “live in 2 different world in many ways,” Minnetronix co-founder Dirk Smith...
View ArticleClik here to view.
ICU Medical touts dosing errors study
ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira...
View ArticleClik here to view.
PharmaJet expands needle-free delivery of influenza vaccines
PharmaJet said today that a trivalent and quadrivalent influenza vaccine is available with its Stratis needle-free injector for this year’s flu season. PharmaJet’s device is designed to administer...
View ArticleClik here to view.
Pfizer appeals $107m fine for anti-epilepsy drug prices in UK
Pfizer (NYSE:PFE) and Flynn Pharma have appealed the record $107 million (£84.2 million) and $6.5 million (£5.2 million) fines imposed by the U.K. Competition & Markets Authority in December for...
View ArticleClik here to view.
Collecting purposeful data in the era of connected health devices
Connectivity, one of the newest buzzwords in the medical device lexicon, is becoming more and more integral to device design and development. Research shows that connected health devices can improve...
View ArticleClik here to view.
Anika beats Q4 earnings, revenue estimates
Shares in Anika Therapeutics (NSDQ:ANIK) fell today, even though the orthopedic medicines company beat expectations on Wall Street with its 4th quarter results. The Bedford, Mass.-based company posted...
View ArticleClik here to view.
Insulet opens manufacturing facility in Acton, Mass.
Insulet (NSDQ:PODD) said yesterday that it acquired a manufacturing facility in Acton, Mass. The Billerica, Mass.-based company said that its new facility will allow Insulet to more efficiently...
View ArticleClik here to view.
How Sanofi blew its chance with Actelion
Days before entering into exclusive takeover negotiations with Johnson & Johnson (NYSE:JNJ), Actelion (VTX:ATLN) was reportedly fielding an offer from Sanofi (NYSE:SNY). But the Swiss biotech...
View ArticleClik here to view.
Clearside enrolls first patient in phase III trial of Zuprata combination...
Clearside Biomedical (NSDQ:CLSD) said today that it enrolled the 1st patient in a phase III trial evaluating Zuprata, its suspension formulation of triamcinolone acetonide, in combination with Eylea...
View ArticleClik here to view.
Cytori launches nanoparticle program after acquiring Azaya Therapeutics
Cytori Therapeutics (NSDQ:CYTX) said yesterday that it completed its acquisition of San Antonio-based Azaya Therapeutics and its nanoparticle cancer drugs. In late January, San Diego-based Cytori said...
View ArticleClik here to view.
Windtree touts preclinical data from influenza study for aerosolized surfactant
Windtree Therapeutics (NSDQ:WINT) said today that a preclinical influenza study demonstrated that its aerosolized KL4 surfactant reduced lung inflammation and improved overall survival in ferrets. In...
View ArticleClik here to view.
QuiO adds MedCrypt data security to Smartinjector pen
MedCrypt and QuiO said earlier this month that the companies are partnering to integrate MedCrypt’s data security software into QuiO’s Smartinjector devices. According to the agreement, MedCrypt will...
View ArticleClik here to view.
CMS nominee Verma: Mylan’s EpiPen case ‘disturbing’
Seema Verma, the nominee to head the Centers for Medicare & Medicaid, said at her confirmation hearing that she would like to review the way pharmaceutical companies classify products as generic or...
View ArticleClik here to view.
CareFusion expands Alaris warning
The U.K.’s Medicines & Healthcare Products Regulatory Agency issued an 2nd warning for CareFusion’s Alaris drug pump after the company discovered that the Alaris pumps with broken springs in the...
View ArticleClik here to view.
Adapt Pharma seeks regulatory nod for naloxone nasal spray in Europe
Adapt Pharma said today that it filed a European Marketing Application for its naloxone hydrochloride nasal spray for the treatment of opioid overdose. The Dublin-based company’s product is a...
View ArticleClik here to view.
Common Sensing, Welkin Health collaborate on digital diabetes management system
Common Sensing and Welkin Health said last month that the companies are partnering to develop a digital diabetes management program designed to improve insulin adherence. The companies plan to craft a...
View ArticleClik here to view.
Researchers develop smart drugs using ‘DNA computers’ for controlled delivery
Researchers from the Eindhoven University of Technology have developed the 1st “DNA computer” that can detect several antibodies in the blood and perform calculations based on what it detects. The team...
View Article